CNA FINANCIAL CORP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
CNA FINANCIAL CORP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2022$367,000
-20.2%
11,100
-15.1%
0.14%
-13.0%
Q2 2022$460,000
-26.4%
13,070
-3.8%
0.16%
-17.0%
Q1 2022$625,000
-25.9%
13,590
+6.8%
0.19%
-12.2%
Q4 2021$844,00012,7300.22%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders